Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04138940 · ClinicalTrials.gov registry record · NA
Modulating Intensity and Dosage of Aphasia Scripts
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT04138940 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 85 participants.
The verdict
NCT04138940, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how changing conditions of speech-language treatment (namely, amount of repetition and distribution of practice schedule) affects the language outcome of participants with aphasia following a stroke. Using a computer based speech and language therapy program, participants will practice conversational scripts that are either short or long. Participants will practice for either 2 weeks (5 days a week) or for 5 weeks (2 days a week).
Interventions
- BEHAVIORAL Script Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04138940
The ClinicalTrials.gov registry entry for NCT04138940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Script Training is the first listed.
NCT04138940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04138940 about?
NCT04138940 is a clinical study titled "Modulating Intensity and Dosage of Aphasia Scripts". The purpose of this study is to evaluate how changing conditions of speech-language treatment (namely, amount of repetition and distribution of practice schedule) affects the language outcome of participants with aphasia following a stroke. Using a computer based speech and language therapy program,...
What is the current status of trial NCT04138940?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2020-09-21. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT04138940?
The interventions under investigation include: Script Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04138940?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.